30 results
DEF 14A
NTBL
Notable Labs Ltd
16 Feb 24
Definitive proxy
9:00am
time to time in order to ensure that levels of executive compensation, as compared to the overall workforce will not have a negative impact on work
PRE 14A
NTBL
Notable Labs Ltd
5 Feb 24
Preliminary proxy
5:00pm
to be examined by Notable from time to time in order to ensure that levels of executive compensation, as compared to the overall workforce
424B3
NTBL
Notable Labs Ltd
5 Sep 23
Prospectus supplement
6:02pm
result in a suspension of trading and possible delisting.
VBL has undergone a significant workforce reduction to reduce operating expenses … reduced its workforce and currently has only seven full-time employees. As part of the organizational streamlining, Dr. Ron Cohen, Dr. Bennett
S-4/A
a7tbsag93yixnxx8fhis
30 Jun 23
Registration of securities issued in business combination transactions (amended)
4:38pm
10-Q
83d0buepomvi1anq106
15 May 23
Quarterly report
4:30pm
S-4
0za52qbbuwaf ezri9
11 May 23
Registration of securities issued in business combination transactions
9:09am
6-K
EX-99.3
1btjyrwc
14 Nov 22
VBL Therapeutics Reports Third Quarter 2022 Financial Results
4:19pm
6-K
EX-99.2
fy6zw97x i4osc4
14 Nov 22
VBL Therapeutics Reports Third Quarter 2022 Financial Results
4:19pm
6-K
EX-99.1
iiqhsj 090j
14 Nov 22
VBL Therapeutics Reports Third Quarter 2022 Financial Results
4:19pm
6-K
EX-99.1
17wlp
15 Aug 22
VBL Therapeutics Announces Second Quarter 2022 Financial Results
4:07pm
6-K
EX-99.2
8d255gkowuxjy 0ucf
15 Aug 22
VBL Therapeutics Announces Second Quarter 2022 Financial Results
4:07pm
6-K
EX-99.3
t0n9i6aqqogc
15 Aug 22
VBL Therapeutics Announces Second Quarter 2022 Financial Results
4:07pm
6-K
vpjt1az3kg7m06lk1
2 Aug 22
VBL Therapeutics Announces Workforce Reduction
8:32am
6-K
EX-99.1
dqk9ds
2 Aug 22
VBL Therapeutics Announces Workforce Reduction
8:32am